BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22945651)

  • 1. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
    Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
    Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer.
    Yoo SS; Lee SM; Do SK; Lee WK; Kim DS; Park JY
    Lung Cancer; 2014 Oct; 86(1):85-90. PubMed ID: 25172267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer.
    Paliwal A; Vaissière T; Krais A; Cuenin C; Cros MP; Zaridze D; Moukeria A; Boffetta P; Hainaut P; Brennan P; Herceg Z
    Cancer Res; 2010 Apr; 70(7):2779-88. PubMed ID: 20332232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
    Zienolddiny S; Skaug V; Landvik NE; Ryberg D; Phillips DH; Houlston R; Haugen A
    Carcinogenesis; 2009 Aug; 30(8):1368-71. PubMed ID: 19465454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.
    Liu Q; Han H; Wang M; Yao Y; Wen L; Jiang K; Ma Y; Fan R; Chen J; Su K; Yang Z; Cui W; Yuan W; Jiang X; Li J; Payne TJ; Wang J; Li MD
    Transl Psychiatry; 2018 Apr; 8(1):83. PubMed ID: 29666375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
    Hwang JA; Kim Y; Hong SH; Lee J; Cho YG; Han JY; Kim YH; Han J; Shim YM; Lee YS; Kim DH
    PLoS One; 2013; 8(11):e79634. PubMed ID: 24265783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
    Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
    Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.
    Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
    Oncogene; 2002 May; 21(19):3020-8. PubMed ID: 12082532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations.
    Tekpli X; Landvik NE; Skaug V; Gulsvik A; Haugen A; Zienolddiny S
    Int J Cancer; 2013 Apr; 132(8):1811-20. PubMed ID: 23011884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.
    Tessema M; Yingling CM; Liu Y; Tellez CS; Van Neste L; Baylin SS; Belinsky SA
    Carcinogenesis; 2014 Jun; 35(6):1248-57. PubMed ID: 24398667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.